Who
William Go
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Janux Therapeutics.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Feb 2026
- Last trade
- 2 Feb 2026
- Last filed
- 4 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Feb 2026filed 4 Feb 2026 | JANX Janux TherapeuticsBiotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 2 Feb 2026filed 4 Feb 2026 | JANX Janux Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —154,000 at $0.00 | filing |
| 2 Feb 2026filed 4 Feb 2026 | JANX Janux Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —154,000 at $0.00 | filing |
| 2 Feb 2026filed 4 Feb 2026 | JANX Janux TherapeuticsBiotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
News
Tredegar (NYSE:TG) Major Shareholder William Gottwald Sells 35,506 Shares of Stockdailypolitical.com · 21 Oct 2026Opinion: Is William going to fulfill his solemn promise to Diana?dailymail.com · 28 Sep 2026Duolingo (NASDAQ:DUOL) Director William Gordon Sells 10,000 Shares of Stocktickerreport.com · 11 Sep 2026
3 headlines in the last 90 days name William Go; no company of theirs resolves to a name we track.
Sectors
No trade we could place in a sector.